Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
Some breast cancer patients with initial axillary metastasis can achieve axillary complete pathological remission(A-pCR) after neoadjuvant therapy(NAT),These patients are candidates for axillary Surgery de-escalation. This prospective study is designed to evaluate the feasibility and safety of axillary surgery de-escalation for the initial axillary metastasis breast cancer patients who are predicted to achieve A-pCR using multiple pathological indicators and imaging examinations (molecular typing, ultrasound and dedicated breast positron emission tomography, etc.) before and after 1-2 cycles NAT
Epistemonikos ID: e61a340a940030747908932b9caba17f4a2ccf7d
First added on: May 15, 2024